Latest News for: ocular

Edit

With GLP-1 generics making debut, doctors warn of ocular risks

The Times of India 25 Apr 2026
Comments. +Text SizeSmallMediumLarge. .
Edit

Innovative ocular solutions: Improving lives through advanced therapies (Fortrea Holdings Inc)

Public Technologies 23 Apr 2026
Our extensive experience spans multiple indications, from front and back-of-the-eye conditions to rare ocular diseases, cell and gene therapies, pediatrics and ophthalmic devices and [...].
Edit

Ocular Therapeutix™ to Host Investor Day on June 17, 2026

Nasdaq Globe Newswire 22 Apr 2026
Ocular’s Investor Day will take place in New York City, ...
Edit

How Nanoparticle Technologies Aid Ocular Drug Delivery (Ascendia Pharmaceuticals Inc)

Public Technologies 20 Apr 2026
Ocular drug delivery has been a subject of continued interest in development of innovative drugs due, in part, to poor bioavailability (ca ... Overcoming Ocular Barriers ... An ocular dose is typically 5-15 mL (with few exceptions) for commercial eye drops.
Edit

EssilorLuxottica partners with TFOS to advance global standards in ocular surface health (EssilorLuxottica SA)

Public Technologies 17 Apr 2026
) The Company has announced a strategic partnership with the Tear Film & Ocular Surface Society (TFOS), an international non-profit organization dedicated ...
Edit

Rhesus macaques with an OPA1 mutation demonstrate features of autosomal dominant optic atrophy

PNAS 15 Apr 2026
One such condition is autosomal dominant optic atrophy (ADOA), an ... .
Edit

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Nasdaq Globe Newswire 14 Apr 2026
The awards were made as an inducement material to each recipient’s acceptance of employment with Ocular under Ocular’s ...
Edit

Ocular Therapeutix™ Announces Additional Positive Week 52 Data from Landmark SOL-1 Phase 3 Trial of ...

Nasdaq Globe Newswire 13 Apr 2026
New SOL-1 post-hoc analyses presented at VBS reinforce AXPAXLI’s unmatched durability in wet AMD with sustained disease control ... .
Edit

Statement of Changes in Beneficial Ownership (Form 4) (Ocular Therapeutix Inc)

Public Technologies 13 Apr 2026
) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue ... Washington, D.C ... OCULAR THERAPEUTIX, INC [OCUL] 5 ... C/O OCULAR THERAPEUTIX, INC., 15 CROSBY DRIVE 3 ... C/O OCULAR THERAPEUTIX, INC ... Ocular Therapeutix Inc.
Edit

Ocular Therapeutix™ Announces Additional Positive Week 52 Data from Landmark SOL-1 Phase 3 Trial of AXPAXLI™ in Wet AMD (Ocular Therapeutix Inc)

Public Technologies 13 Apr 2026
BEDFORD, Ma., April 13, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc ... Dugel, MD, Executive Chairman, President and Chief Executive Officer of Ocular Therapeutix ... In February 2026, Ocular reported positive SOL-1 Week 52 topline data.
Edit

Look, Resist, Transform: First international Meeting of Survivors of Ocular Violence (OMCT - World Organisation Against Torture)

Public Technologies 09 Apr 2026
Across the world, thousands of people have been blinded or suffered other severe ocular injuries as a result of the unlawful use of force by public security officials ... ocular violence is not incidental, but part of a deliberate pattern of repression.
Edit

Cellution Biologics Inc. Announces Official Entry into the Ocular Market at ASCRS with the Launch ...

Nasdaq Globe Newswire 07 Apr 2026
Cellution Biologics launches OptiCover™, a shelf-stable amniotic graft with HC-HA/PTX3, at ASCRS to address dry eye and ocular surface repair ... .
Edit

Cellution Biologics Inc. Announces Official Entry into the Ocular Market at ASCRS with the

Hastings Tribune 07 Apr 2026
today announced its official entry into the ocular ...
Edit

Ophthalmic Lasers Market Size to Reach USD 2.94 Billion by 2035; Rising Prevalence of Ocular ...

Nasdaq Globe Newswire 06 Apr 2026
U.S ... U.S.
Edit

Ocular Therapeutix™ to Present Additional SOL-1 Data and Analyses at Upcoming Scientific Conferences in April

Nasdaq Globe Newswire 01 Apr 2026
BEDFORD, Mass., April 01, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc ... OCUL, “Ocular”), an ...

Article Search

tools
×
×
×
×